Inspire Medical Q4 preliminary revenue ~$137.7M (+76% YoY); FY22 ~$407.7M (+75%)

Inspire Medical Systems, Inc.

2022-FY EPS reported -$1.60 revenue$407,856,000

Q4 2022 preliminary revenue $137.5M-$137.9M, ~76% YoY increase.
Full-year 2022 revenue $407.5M-$407.9M, ~75% increase over FY 2021.
Activated 61 new U.S. implant centers in Q4 (total 905); added 16 sales territories (total 225).
European revenue growth driven by Germany, Switzerland, and the Netherlands.
Published inaugural Environmental, Social, and Governance (ESG) report.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Inspire Medical Systems, Inc. reported preliminary financial results for quarter and full year ended December 31, 2022.

Period: quarter and full year ended December 31, 2022
Result: preliminary results

Exact text from the filing

On January 9, 2023, Inspire Medical Systems, Inc. (the “Company”) issued a press release announcing certain preliminary and unaudited results for the quarter and full year ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

Inspire Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001609550-23-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.